Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Brooks

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Immunity|April 13, 2022
DC1s shield Tpex cells to bolster PD-1 blockadeDavid G Brooks, Pamela S Ohashi
Journal of Virology|January 19, 2002
Effect of latent human immunodeficiency virus infection on cell surface phenotypeDavid G Brooks, Jerome A Zack
Science (New York, N.Y.)|May 9, 2009
IL-21 is required to control chronic viral infectionHeidi Elsaesser, Karsten Sauer, David G Brooks
Seminars in Immunology|June 4, 2019
Type I interferon signaling, regulation and gene stimulation in chronic virus infectionSabelo Lukhele, Giselle M Boukhaled, David G Brooks
Annual Review of Pathology|December 2, 2020
Opposing Roles of Type I Interferons in Cancer ImmunityGiselle M Boukhaled, Shane Harding, David G Brooks
Gene|June 23, 2005
Increased IRP1 activity in Friedreich ataxiaLioba Lobmayr, David G Brooks, Robert B Wilson
Trends in Immunology|June 6, 2017
Type I Interferon in Chronic Virus Infection and CancerLaura M Snell, Tracy L McGaha, David G Brooks
Trends in Immunology|March 20, 2024
Regulation and impact of tumor-specific CD4<sup>+</sup> T cells in cancer and immunotherapyMengdi Guo, Melissa Yi Ran Liu, David G Brooks
The Journal of Investigative Dermatology|January 8, 2004
Decreased serum ferritin is associated with alopecia in womenJonathan Kantor, Lisa Jay Kessler, David G Brooks, et al.
Clinical Therapeutics|September 24, 2013
Discovery of novel drugs for promising targetsRobert E Martell, David G Brooks, Yan Wang, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Immunity|April 13, 2022
DC1s shield Tpex cells to bolster PD-1 blockadeDavid G Brooks, Pamela S Ohashi
Journal of Virology|January 19, 2002
Effect of latent human immunodeficiency virus infection on cell surface phenotypeDavid G Brooks, Jerome A Zack
Science (New York, N.Y.)|May 9, 2009
IL-21 is required to control chronic viral infectionHeidi Elsaesser, Karsten Sauer, David G Brooks
Seminars in Immunology|June 4, 2019
Type I interferon signaling, regulation and gene stimulation in chronic virus infectionSabelo Lukhele, Giselle M Boukhaled, David G Brooks
Annual Review of Pathology|December 2, 2020
Opposing Roles of Type I Interferons in Cancer ImmunityGiselle M Boukhaled, Shane Harding, David G Brooks
Gene|June 23, 2005
Increased IRP1 activity in Friedreich ataxiaLioba Lobmayr, David G Brooks, Robert B Wilson
Trends in Immunology|June 6, 2017
Type I Interferon in Chronic Virus Infection and CancerLaura M Snell, Tracy L McGaha, David G Brooks
Trends in Immunology|March 20, 2024
Regulation and impact of tumor-specific CD4<sup>+</sup> T cells in cancer and immunotherapyMengdi Guo, Melissa Yi Ran Liu, David G Brooks
The Journal of Investigative Dermatology|January 8, 2004
Decreased serum ferritin is associated with alopecia in womenJonathan Kantor, Lisa Jay Kessler, David G Brooks, et al.
Clinical Therapeutics|September 24, 2013
Discovery of novel drugs for promising targetsRobert E Martell, David G Brooks, Yan Wang, et al.
Pageof 10